Evidence map›Paper›PMID 39331180›Full record

ArticleDiscover oncology2024

Super learner model for classifying leukemia through gene expression monitoring.

Sharanya Selvaraj, Alhuseen Omar Alsayed, Nor Azman Ismail, Balasubramanian Prabhu Kavin, Edeh Michael Onyema, Gan Hong Seng, Arinze Queen Uchechi

Abstract read
In one paragraph

Article in Discover oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sharanya SelvarajDepartment of Data Science and Business Systems, SRM Institute of Science and Technology, Kattankulathur, Chennai, India, 603203.
Alhuseen Omar AlsayedFaculty of Computing, UniversitiTeknologi Malaysia, Johor Bahru, Malaysia.
Nor Azman IsmailFaculty of Computing, UniversitiTeknologi Malaysia, Johor Bahru, Malaysia.
Balasubramanian Prabhu KavinDepartment of Data Science and Business Systems, SRM Institute of Science and Technology, Kattankulathur, Chennai, India, 603203.
Edeh Michael OnyemaDepartment of Mathematics and Computer Science, Coal City University, Enugu, Nigeria. mikedreamcometrue@gmail.com.
Gan Hong SengSchool of AI and Advanced Computing, XJTLU Entrepreneur College (Taicang), Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, People's Republic of China, 215400.
Arinze Queen UchechiSchool or Workplace, University of Nigeria (UNN), Enugu, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukemia is a form of cancer that affects the bone marrow and lymphatic system, and it requires complex treatment strategies that vary with each subtype. Due to the subtle morphological differences among these types, monitoring gene expressions is crucial for accurate classification. Manual or pathological testing can be time-consuming and expensive. Therefore, data-driven methods and machine learning algorithms offer an efficient alternative for leukemia classification. This study introduced a novel super learning model that leverages heterogeneous machine learning models to analyze gene expression data and classify leukemia cells. The proposed approach incorporates an entropy-based feature importance technique to identify the gene profiles most significant to the labeling process. The strength of this super learning model lies in its final super learner, Random Forest, which effectively classifies cross-validated data from the candidate learners. Validation on a gene expression monitoring dataset demonstrates that this model outperforms other state-of-the-art models in predictive accuracy. The study contributes to the knowledge regarding the use of advanced machine learning techniques to improve the accuracy and reliability of leukemia classification using gene expression data, addressing the challenges of traditional methods that rely on clinical features and morphological examination.

Indexed as

DNA microarrayGene expressionsLeukemiaMachine learningRandom forestSuper learner

Identifiers

PMID39331180
PMCPMC11436508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.